--- title: "McKesson Corporation (MCK.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/MCK.US.md" symbol: "MCK.US" name: "McKesson Corporation" industry: "Health Care Distributors" --- # McKesson Corporation (MCK.US) | Item | Detail | |------|--------| | Industry | Health Care Distributors | | Location | US Market | | Website | [www.mckesson.com](https://www.mckesson.com) | ## Company Profile McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-20T04:30:14.000Z **Overall: C (0.44)** **Industry**: Health Care Distributors | Metric | Value | |--------|-------| | Industry Ranking | 3 / 15 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Large - The company has stable operations, allowing for dependable long-term returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 15.49% | | | Net Profit YoY | 53.57% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -88.43 | | | Dividend Ratio | 0.33% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 114.79B | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 397.96B | | **Multi Score**: C #### Profit Score: E | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -198.08% | E | | Profit Margin | 1.09% | C | | Gross Margin | 3.46% | E | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 15.49% | B | | Net Profit YoY | 53.57% | B | | Total Assets YoY | 18.44% | A | | Net Assets YoY | 96.34% | A | #### Cash Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | 9169.54% | A | | OCF YoY | 15.49% | B | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 5.13 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 100.12% | E | ```chart-data:radar { "title": "Longbridge Financial Score - McKesson Corporation", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "E", "indicators": [ { "name": "ROE", "value": "-198.08%", "rating": "E" }, { "name": "Profit Margin", "value": "1.09%", "rating": "C" }, { "name": "Gross Margin", "value": "3.46%", "rating": "E" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "15.49%", "rating": "B" }, { "name": "Net Profit YoY", "value": "53.57%", "rating": "B" }, { "name": "Total Assets YoY", "value": "18.44%", "rating": "A" }, { "name": "Net Assets YoY", "value": "96.34%", "rating": "A" } ] }, { "name": "Cash", "grade": "A", "indicators": [ { "name": "Cash Flow Margin", "value": "9169.54%", "rating": "A" }, { "name": "OCF YoY", "value": "15.49%", "rating": "B" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "5.13", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "100.12%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Cencora (US.COR) | B | B | A | E | B | B | | 02 | Henry Schein (US.HSIC) | B | C | A | D | B | B | | 03 | McKesson (US.MCK) | E | B | A | E | A | C | | 04 | Cardinal Health (US.CAH) | E | B | A | E | A | C | | 05 | AdaptHealth (US.AHCO) | C | C | B | D | B | C | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 26.74 | 3/13 | 29.63 | 27.17 | 26.00 | | PB | -89.41 | 12/13 | - | - | - | | PS (TTM) | 0.29 | 5/13 | 0.26 | 0.25 | 0.24 | | Dividend Yield | 0.32% | 3/13 | 0.41% | 0.39% | 0.37% | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-17T05:00:00.000Z Total Analysts: **17** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 10 | 59% | | Overweight | 3 | 18% | | Hold | 4 | 24% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 947.48 | | Highest Target | 1000.00 | | Lowest Target | 760.00 | ## References - [Company Overview](https://longbridge.com/en/quote/MCK.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/MCK.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/MCK.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.